Clariane Raises €500M in Bonds at 6.875%, Experiences High Over-Subscription
Clariane has announced the successful issuance of €500 million in senior bonds maturing in 2031, denominated in euros and bearing an annual interest rate of 6.875%.
Clariane has issued €500 million in new senior bonds denominated in euros, maturing in 2031. The bonds were issued at 100% of their face value and will bear interest at an annual rate of 6.875%. The offering attracted significant over-subscription from institutional investors both in France and internationally. The settlement-delivery date is scheduled for April 16, 2026.
Purpose of the Funds
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Clariane plans to use the net proceeds from the offering, along with its available cash, to refinance its Schuldschein maturing in 2026 and 2027, as well as its Euro PP bonds maturing in 2027 and 2028, either at maturity or earlier.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 1T2026
Key reported figures
Revenue: 1336M€
Guidance from the release
Avec une croissance organique de 4,9 %, le premier trimestre 2026 s’inscrit pleinement dans la dynamique.
Le chiffre d’affaires au 31 mars 2026 s’établit à €1 336m, en progression de +4,9%.
Risks mentioned
Impact des cessions intervenues en 2025 dans le cadre du plan de renforcement.
Risque lié aux conditions de marché futures.
Effets des défis réglementaires dans le secteur.
Opportunities identified
Lancement d'une obligation senior de €500m à échéance 2031.
Nouvelle dynamiqueprix/volume grâce aux mesures d’adaptation mises en place.
Engagement fort des collaborateurs pour atteindre les objectifs opérationnels.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
